Chewy, Inc. quarterly report, Q2 FY2022

Chewy, Inc. — Form 10-Q Summary

Period: The filing covers the 13 and 26 weeks ended July 31, 2022, compared with periods ended August 1, 2021. The request metadata says “2021 Q2,” but the filing itself is for fiscal Q2 2022.

Business context and performance

Chewy is an e-commerce retailer of pet products and services. For the quarter, net sales rose 12.8% to $2.431 billion. Growth reflected higher spending per customer and a larger active-customer base; Autoship customer sales were 73.1% of sales.

Metric13 weeks ended July 31, 2022Prior-year period26 weeks ended July 31, 2022Prior-year period
Net sales$2.431B$2.155B$4.859B$4.290B
Gross profit / margin$682.8M / 28.1%$593.5M / 27.5%$1.351B / 27.8%$1.183B / 27.6%
Operating income (loss) / margin$21.7M / 0.9%($16.2M) / (0.8%)$40.5M / 0.8%$22.9M / 0.5%
Net income (loss) / margin$22.3M / 0.9%($16.7M) / (0.8%)$40.8M / 0.8%$22.0M / 0.5%
Adjusted EBITDA (non-GAAP) / margin$83.1M / 3.4%$23.3M / 1.1%$143.6M / 3.0%$100.6M / 2.3%
Operating cash flow$49.2M$85.1M$131.6M$183.5M
Free cash flow (non-GAAP)$1.0M$60.3M$7.4M$119.7M

Financial position and material changes

  • Cash and cash equivalents were $606.8 million at July 31, 2022. Current assets were $1.505 billion and current liabilities $1.778 billion, implying negative working capital of about $272.9 million.
  • Chewy had no borrowings under its $500 million asset-based revolving facility and reported $449.9 million of available borrowing capacity. Operating lease liabilities totaled $479.5 million; these are lease obligations, not disclosed funded borrowings.
  • For the first half, capital expenditures increased to $124.2 million from $63.7 million. Inventory rose $147.5 million and contributed to weaker operating cash flow; the filing attributes the investment spending largely to new and future fulfillment centers and IT.
  • Quarterly sales increased in consumables and other products, while hardgoods sales fell 8.7%. Active customers grew 2.1% year over year to 20.49 million; net sales per active customer rose 14.4% to $462.
  • Quarterly SG&A rose 18.1%, including higher facilities, fulfillment, headcount, technology and share-based compensation costs. Advertising and marketing expense fell 16.2%.

Outlook, risks and unusual items

  • No specific revenue, earnings or margin guidance is provided. Management said cash and cash equivalents plus revolving-facility availability should fund working capital, capital expenditures and contractual obligations for at least the next 12 months.
  • Management cited challenging fulfillment-center labor markets, supply-chain disruptions and shortages, inflation, and uncertainty around COVID-19 and consumer spending as ongoing risks affecting operations, sales and margins.
  • IBM’s patent case had a favorable district-court ruling for Chewy in April 2022: the court found no infringement on three patents and invalidated a fourth. IBM appealed and filed its appellate brief in August 2022; Chewy said it would continue to defend itself.
  • The company recorded no income-tax provision for the reported periods and maintained a full valuation allowance on net deferred tax assets. Share-based compensation expense was $38.4 million for the quarter and $64.2 million for the first half.
  • Management reported effective disclosure controls at a reasonable-assurance level and no material change in internal control over financial reporting during the quarter.

Important facts for investors to verify

  • Confirm the reporting period: the filing is Q2 2022, not Q2 2021, as the request metadata indicates.
  • Track whether improved gross and operating margins persist as fulfillment, labor, freight and other operating costs evolve.
  • Assess the cash-flow impact of inventory and capital spending; first-half free cash flow was sharply lower year over year despite higher net income.
  • Review the composition and recurrence of Adjusted EBITDA adjustments and the effects of ongoing share-based compensation.
  • Monitor liquidity, including working-capital requirements, borrowing-base availability and lease commitments.
  • Follow the IBM appeal and any developments that could affect the litigation exposure.